Ceritinib Impurity 29 CAS CATO-C4X-104829
| CAS No. | CATO-C4X-104829 |
| Molecular Formula | C22H23N2O3 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Ceritinib Impurity 29.
Ceritinib Impurity 29 (CAS CATO-C4X-104829) is a certified pharmaceutical impurity reference standard with the molecular formula C22H23N2O3Br and a molecular weight of 443.34 g/mol.
Owing to a steroid core, an amide group, a hydroxyl group, an ether linkage, bromine substitution, Ceritinib Impurity 29 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 443.34 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Ceritinib Impurity 29 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C22H23N2O3 Br |
| Molecular Weight | 443.34 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 2 |
Related Ceritinib Standards
- Ceritinib Impurity 86 (CAS /)
- Ceritinib (CAS 1032900-25-6)
- Ceritinib dihydrochloride (CAS 1380575-43-8)
- Ceritinib Impurity 88 (CAS 1823331-67-4)
- Ceritinib Impurity 87 (CAS 2976-70-7（free base))
- Ceritinib Impurity 85 (CAS 761440-17-9)
- Ceritinib Impurity 19 (CAS 771555-72-7)
- Ceritinib Impurity 2 (CAS 861343-73-9)
Recommended Standards
- Pregabalin Impurity PD 0312237 & PD 0312236 Mixture (CAS CATO-C4X-13125)
- Norepinephrine Impurity 51 (CAS 73917-81-4)
- Norfloxacin Impurity 50 (CAS CATO-C4X-146850)
- N,N-Diethyl-2-(piperidin-4-yloxy)-acetamide (CAS 1097828-89-1)
- n-(2-Fluorobenzyl)-2-morpholinoethan-1-amine (CAS 626209-54-9)
- (R)-N1-Cyclopropyl-N1-(1-methylpiperidin-3-yl)ethane-1,2-diamine (CAS 1354000-84-2)
- 1-((5-Bromo-4-hydrazinylpyridin-3-yl)sulfonyl)azepane (CAS 1352517-27-1)
- 3-(3-Chloro-2-fluorophenoxy)propanenitrile (CAS 1378336-28-7)
- 3-fluoro-5-methylbenzene-1-sulfonamide (CAS 1384429-42-8)
- Rac1 Inhibitor F56, control peptide (CAS 1315378-77-8)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com